0376-2491
2014 Issue 30
ying jin yi bu jia qiang dui fei xiao xi bao fei ai ba xiang zhi liao de yan jiu
qian gui sheng ;, wu guo ming ;
qian gui sheng ;, wu guo ming ;
..............page:2321-2323
egfr-tki de nai yao ji zhi ji ying dui ce lue
song yong ;, yao yan zuo ;
song yong ;, yao yan zuo ;
..............page:2324-2326
Value of carcinoembryonic antigen levels in predicting the efficacy of EGFR-TKI in advanced nonsmall cell lung cancer harboring EGFR mutations
han bao hui ;, huang ai mi ;, jin bo ;, li zuo ;, lou zuo qing ;, niu yan jie ;, zhang xue yan ;, zhang yan wei ;
han bao hui ;, huang ai mi ;, jin bo ;, li zuo ;, lou zuo qing ;, niu yan jie ;, zhang xue yan ;, zhang yan wei ;
..............page:2327-2331
Clinicopathological features associated with EGFR gene mutation in non-small cell lung cancer patients
Ding Wei;,Mo Weifang;,Zhao Jing;,Zheng Jing;,Zhou Jianya;,Zhou Jianying;
Ding Wei;,Mo Weifang;,Zhao Jing;,Zheng Jing;,Zhou Jianya;,Zhou Jianying;
..............page:2332-2336
Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma
huang yi sheng ;, liao ri qiang ;, lou na na ;, xu chong rui ;, yan hong hong ;, yang zuo ji ;, yang xue ning ;, yang yan ;, zhou qing ;
huang yi sheng ;, liao ri qiang ;, lou na na ;, xu chong rui ;, yan hong hong ;, yang zuo ji ;, yang xue ning ;, yang yan ;, zhou qing ;
..............page:2337-2341
Therapeutic efficacy and safety of chemotherapy subsequent EGFR-TKI in advanced non-small cell lung cancer patients with EGFR-TKI acquired resistance
Bai Chunxue;,Hong Qunying;,Hu Jie;,Li Jiamin;,Zhang Xin;
Bai Chunxue;,Hong Qunying;,Hu Jie;,Li Jiamin;,Zhang Xin;
..............page:2342-2345
Myocardial protective effect of Danhong Injection evaluated by velocity vector imaging in patients undergoing percutaneous coronary intervention
chen jin song ;, chen yun zuo ;, dong jing ;, liu hong xu ;, tian feng ;, wang jing ;, zhi guang ;, zhou ying ;
chen jin song ;, chen yun zuo ;, dong jing ;, liu hong xu ;, tian feng ;, wang jing ;, zhi guang ;, zhou ying ;
..............page:2346-2349
Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: a meta-analysis of outcomes
Li Jianhua;,Li Peihuan;,Liu Bingqian;,Wang Yikun;,Wu Yudong;
Li Jianhua;,Li Peihuan;,Liu Bingqian;,Wang Yikun;,Wu Yudong;
..............page:2350-2354
Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node ≤ 2
Fan Zhaoqing;,Gao Yajun;,He Yingjian;,Ouyang Tao;
Fan Zhaoqing;,Gao Yajun;,He Yingjian;,Ouyang Tao;
..............page:2355-2358
Clinical observation on laparoscopic radiofrequency ablation assisted enucleation for the renal epithelial angimyolipoma
Guo Hongqian;,Yang Rong;,Yang Yang;
Guo Hongqian;,Yang Rong;,Yang Yang;
..............page:2359-2362
Study on the reference range of reticulocyte multi-parameter in newborn from Beijing
Chen Rui;,Li Haibin;,Lu Xinxin;,Wang Zhihai;,Zhang Ling;,Zhang Xin;
Chen Rui;,Li Haibin;,Lu Xinxin;,Wang Zhihai;,Zhang Ling;,Zhang Xin;
..............page:2363-2365
Clinical characteristics of drug hypersensitivity syndrome in 10 patients
chen dian ;, jia li ;, qu tao ;, ren rong zuo ;, shu chang ;, shu dan ;, sun qiu ning ;, zuo cui yan ;, zhao wen ling ;
chen dian ;, jia li ;, qu tao ;, ren rong zuo ;, shu chang ;, shu dan ;, sun qiu ning ;, zuo cui yan ;, zhao wen ling ;
..............page:2366-2368
Interventional treatment of massive hemorrhage after percutaneous nephrolithotomy
Shen Bohua;,Tan Fuqing;,Xu Shunliang;,Zhao Yilei;,Zhong Baishu;
Shen Bohua;,Tan Fuqing;,Xu Shunliang;,Zhao Yilei;,Zhong Baishu;
..............page:2369-2371
Isolation and identification of a non-enterotoxigenic strain of Bacteroides fragilis from a healthy term infant
Bai Yang;,Liu Yangyang;,Zhang Wendi;,Zhi Fachao;
Bai Yang;,Liu Yangyang;,Zhang Wendi;,Zhi Fachao;
..............page:2372-2374
Application of three-dimensional laparoscopy in radical gastric cancer surgery
Fang Yuejun;,Hong Qiang;,Hu Conggang;,Liu Tao;,Tong Qin;,Wang Jianjun;,Wang Yong;
Fang Yuejun;,Hong Qiang;,Hu Conggang;,Liu Tao;,Tong Qin;,Wang Jianjun;,Wang Yong;
..............page:2375-2376
Effect of PD-1 deficiency on atherogenic immune responses
Sun Ning;,Wang Lili;,Xiao Guanghui;,Zhuge Xin;
Sun Ning;,Wang Lili;,Xiao Guanghui;,Zhuge Xin;
..............page:2377-2381
Expression of CCDC67 mRNA and its role in patients with papillary thyroid carcinoma
Jiang Jinhua;,Li Hongqiang;,Wang Qingduan;,Wang Yongfei;,Xu Jianhui;,Yin Detao;,Zhang Yan;
Jiang Jinhua;,Li Hongqiang;,Wang Qingduan;,Wang Yongfei;,Xu Jianhui;,Yin Detao;,Zhang Yan;
..............page:2382-2385
zhong xing li xi bao cd64 yang xing zhi shu zai xue ye bing huan zhe gan ran zhen duan zhong de ying yong jia zhi
chai xiao ;, cui rui ;, deng zuo ;, geng li ;, li qing ;, li yu ming ;, meng juan xia ;, mu juan ;, zhao ming feng ;
chai xiao ;, cui rui ;, deng zuo ;, geng li ;, li qing ;, li yu ming ;, meng juan xia ;, mu juan ;, zhao ming feng ;
..............page:2386-2388
dai xie zu xue ji shu zai zhi qi guan xiao chuan he man xing zu sai xing fei ji bing zhong de ying yong
chang chun ;, zhao jiang chao ;
chang chun ;, zhao jiang chao ;
..............page:2389-2391
shen jing yin su zai zhi liao xing xue guan sheng cheng zhong de yan jiu jin zhan
diao yong peng ;, li yong jun ;
diao yong peng ;, li yong jun ;
..............page:2392-2394
wei xiao rna jie dao de rna ji huo de yan jiu jin zhan
li ling ;, xing chao feng ;, zhou guo ping ;
li ling ;, xing chao feng ;, zhou guo ping ;
..............page:2395-2397
..............page:2398-2399
mei ke er zuo shi ban yi wei yi xian bing fa ji xing chang tao die yi li
cai zhen zhai ;, he yun ;, jiang yi ;, lu guang rong ;, xu chang long ;, xue zhan xiong ;, ye meng si ;, zhou ling ling ;, zhou yu li ;
cai zhen zhai ;, he yun ;, jiang yi ;, lu guang rong ;, xu chang long ;, xue zhan xiong ;, ye meng si ;, zhou ling ling ;, zhou yu li ;
..............page:2400